Drug & intervention
tovorafenib Powder for Oral Suspension [Ojemda]
RxCUI 2682444
What this record represents
SBDF · RxNormThis is an RxNorm SBDF drug concept. Its name, formulation details and source identifiers are preserved to distinguish it from other drug records.
What this record does not establish: current marketing availability, therapeutic equivalence, safety, or official approval status. Check an up-to-date product label or a pharmacist for product-specific questions.
Related drug records
RxNorm name matchesThese are other published drug concepts with matching brand or formulation names. They are not necessarily equivalent medicines.
OjemdaBN · CureCurrent ID 77513
tovorafenib 100 MG [Ojemda]SBDC · CureCurrent ID 77519
tovorafenib 300 MG [Ojemda]SBDC · CureCurrent ID 77560
tovorafenib Oral Tablet [Ojemda]SBDF · CureCurrent ID 77520
tovorafenib 100 MG Oral Tablet [Ojemda]SBD · CureCurrent ID 77521
tovorafenib 300 MG Powder for Oral Suspension [Ojemda]SBD · CureCurrent ID 77515
{16 (tovorafenib 100 MG Oral Tablet [Ojemda]) } Pack [Ojemda 400 MG Once Weekly Carton]BPCK · CureCurrent ID 77939
{20 (tovorafenib 100 MG Oral Tablet [Ojemda]) } Pack [Ojemda 500 MG Once Weekly Carton]BPCK · CureCurrent ID 77941
{24 (tovorafenib 100 MG Oral Tablet [Ojemda]) } Pack [Ojemda 600 MG Once Weekly Carton]BPCK · CureCurrent ID 77943
Molecular structure
Active ingredient: tovorafenibAdvertisement
Conditions being studied
Drug identity and terminology: RxNorm. Trial relationships: ClinicalTrials.gov.